Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 4 Interventional

Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial

ClinicalTrials.gov ID: NCT05208190

Public ClinicalTrials.gov record NCT05208190. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 1:24 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT05208190
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 4
Lead sponsor
New York State Psychiatric Institute
Other
Enrollment
280 participants

Conditions and interventions

Interventions

  • Clozapine Drug
  • treatment as usual Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 16, 2022
Primary completion
Jun 29, 2028
Completion
Dec 30, 2028
Last update posted
May 3, 2026

2022 – 2028

United States locations

U.S. sites
7
U.S. states
5
U.S. cities
5
Facility City State ZIP Site status
University of California, Los Angeles Los Angeles California 90024 Recruiting
Augusta University Research Institute, Inc. Augusta Georgia 30912 Recruiting
University of Maryland School of Medicine Baltimore Maryland 21201 Recruiting
NYU Langone Medical Center New York New York 10016 Recruiting
New York State Psychiatric Institute New York New York 10032 Recruiting
Manhattan Psychiatric Center New York New York 10035 Recruiting
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05208190, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 3, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05208190 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →